Related references
Note: Only part of the references are listed.Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study
Peter Rossing et al.
DIABETES CARE (2022)
Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy
Peter Rossing et al.
KIDNEY INTERNATIONAL REPORTS (2022)
Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease
Xue-qi Liu et al.
ACTA PHARMACOLOGICA SINICA (2022)
US Renal Data System 2021 Annual Data Report: Epidemiology of Kidney Disease in the United States
Kirsten L. Johansen et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2022)
The Role of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in the Prevention and Treatment of Diabetic Kidney Disease Insights from the AMPLITUDE-O Trial
Kalie L. Tommerdahl et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)
Calycosin plays a protective role in diabetic kidney disease through the regulation of ferroptosis
Di Huang et al.
PHARMACEUTICAL BIOLOGY (2022)
Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies
Haojia Wu et al.
CELL METABOLISM (2022)
Nrf2 deficiency deteriorates diabetic kidney disease in Akita model mice
Yexin Liu et al.
REDOX BIOLOGY (2022)
The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists
Giulia Bendotti et al.
PHARMACOLOGICAL RESEARCH (2022)
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes
Hiroki Kobayashi et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study
Elisa Lazzaroni et al.
PHARMACOLOGICAL RESEARCH (2022)
Multimodal single cell sequencing implicates chromatin accessibility and genetic background in diabetic kidney disease progression
Parker C. Wilson et al.
NATURE COMMUNICATIONS (2022)
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA(1c) and Insulin Use: An Analysis From the FIDELIO-DKD Study
Peter Rossing et al.
DIABETES CARE (2022)
Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000-2015
Hui-Teng Cheng et al.
DIABETES CARE (2021)
Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease
Federica Piani et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2021)
Characterization of ferroptosis in kidney tubular cell death under diabetic conditions
Seonghun Kim et al.
CELL DEATH & DISEASE (2021)
Retinal microvascular signs and risk of diabetic kidney disease in asian and white populations
Simon Nusinovici et al.
SCIENTIFIC REPORTS (2021)
From bulk, single-cell to spatial RNA sequencing
Xinmin Li et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2021)
Trends in Chronic Kidney Disease Care in the US by Race and Ethnicity, 2012-2019
Chi D. Chu et al.
JAMA NETWORK OPEN (2021)
The IL-8-CXCR1/2 axis contributes to diabetic kidney disease
Cristian Loretelli et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm
Alieh Gholaminejad et al.
BMC NEPHROLOGY (2021)
Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy
Shuangwen Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
NF-κB System Is Chronically Activated and Promotes Glomerular Injury in Experimental Type 1 Diabetic Kidney Disease
Orestes Foresto-Neto et al.
FRONTIERS IN PHYSIOLOGY (2020)
RIPK1 Activation Induces Necroptosis, Proinflammation, and Profibrosis in Kidney of STZ/HFD-Induced Diabetic Mice
Qing Chen et al.
DIABETES (2020)
Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study)
Masaomi Nangaku et al.
KIDNEY INTERNATIONAL REPORTS (2020)
RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy
Ying Shi et al.
SCIENTIFIC REPORTS (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Connectivity mapping of glomerular proteins identifies dimethylaminoparthenolide as a new inhibitor of diabetic kidney disease
Julie Klein et al.
SCIENTIFIC REPORTS (2020)
The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease
Igor Kravets et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2020)
Klotho attenuates diabetic nephropathy in db/db mice and ameliorates high glucose-induced injury of human renal glomerular endothelial cells
Qi Wang et al.
CELL CYCLE (2019)
Cell death: a review of the major forms of apoptosis, necrosis and autophagy
Mark S. D'Arcy
CELL BIOLOGY INTERNATIONAL (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The single-cell transcriptomic landscape of early human diabetic nephropathy
Parker C. Wilson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression
Ying Fan et al.
DIABETES (2019)
Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice
Chao Zheng et al.
CELL DEATH & DISEASE (2019)
Sodium-Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease
Radica Z. Alicic et al.
DIABETES (2019)
Association between thyroid function and diabetic nephropathy in euthyroid subjects with type 2 diabetes mellitus: a cross-sectional study in China
Jian Wang et al.
Oncotarget (2019)
Histological Evidence of Diabetic Kidney Disease Precede Clinical Diagnosis
Giorgia Comai et al.
AMERICAN JOURNAL OF NEPHROLOGY (2019)
The Landscape of Diabetic Kidney Disease in the United States
O. Kenrik Duru et al.
CURRENT DIABETES REPORTS (2018)
Biomarkers of diabetic kidney disease
Helen M. Colhoun et al.
DIABETOLOGIA (2018)
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Hans-Joachim Anders et al.
NATURE REVIEWS NEPHROLOGY (2018)
Association between Thyroid Hormone Levels and Diabetic Kidney Disease in Euthyroid Patients with Type 2 Diabetes
Jian Zou et al.
SCIENTIFIC REPORTS (2018)
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Katherine R. Tuttle et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Diagnosis of diabetic kidney disease: state of the art and future perspective
Frederik Persson et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2018)
Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes
Julie A. Lovshin et al.
JCI INSIGHT (2018)
Diabetes with early kidney involvement may shorten life expectancy by 16 years
Chi Pang Wen et al.
KIDNEY INTERNATIONAL (2017)
Diabetic Kidney Disease Challenges, Progress, and Possibilities
Radica Z. Alicic et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy
Wilhelm Kriz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative
Antonio Pacilli et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Vascular endothelium in diabetes
Michael S. Goligorsky
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Podocytes: the Weakest Link in Diabetic Kidney Disease?
Jamie S. Lin et al.
CURRENT DIABETES REPORTS (2016)
Caspase-1, but Not Caspase-3, Promotes Diabetic Nephropathy
Khurrum Shahzad et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
An autopsy study suggests that diabetic nephropathy is underdiagnosed
Celine Q. F. Klessens et al.
KIDNEY INTERNATIONAL (2016)
Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study
Bogdan Ene-Iordache et al.
LANCET GLOBAL HEALTH (2016)
Multiple Genes of the Renin-Angiotensin System Are Novel Targets of Wnt/beta-Catenin Signaling
Lili Zhou et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Glomerular endothelial cell injury and cross talk in diabetic kidney disease
Jia Fu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Role of Transcription Factor Acetylation in Diabetic Kidney Disease
Ruijie Liu et al.
DIABETES (2014)
Role of Podocyte B7-1 in Diabetic Nephropathy
Paolo Fiorina et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE-/- Mice
Sian P. Cartland et al.
PLOS ONE (2014)
MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates
Yves Dondelinger et al.
CELL REPORTS (2014)
Renal Lesions Predict Progression of Diabetic Nephropathy in Type 1 Diabetes
M. Luiza Caramori et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury
Simone M. Blattner et al.
KIDNEY INTERNATIONAL (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Podocyte vascular endothelial growth factor (Vegf 164 ) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes
D. Veron et al.
DIABETOLOGIA (2011)
Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes
Yi Lin et al.
JOURNAL OF ENDOCRINOLOGY (2011)
The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy
Tao Jiang et al.
DIABETES (2010)
Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort
Esther Meijer et al.
KIDNEY INTERNATIONAL (2010)
The death ligand TRAIL in diabetic nephropathy
Corina Lorz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Modular activation of nuclear factor-κB transcriptional programs in human diabetic nephropathy
Holger Schmid et al.
DIABETES (2006)
Risk factors for renal dysfunction in type 2 diabetes - UK prospective diabetes study 74
Ravi Retnakaran et al.
DIABETES (2006)
Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients - A phosphorous-31 magnetic resonance spectroscopy study
G Perseghin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
TRAIL and apoptosis induction by TNF-family death receptors
SL Wang et al.
ONCOGENE (2003)
Nephrin expression is reduced in human diabetic nephropathy - Evidence for a distinct role for glycated albumin and angiotensin II
S Doublier et al.
DIABETES (2003)
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
AI Adler et al.
KIDNEY INTERNATIONAL (2003)
Patient survival and cardiovascular events after kidney-pancreas transplantation: Comparison with kidney transplantation alone in uremic IDDM patients
E La Rocca et al.
CELL TRANSPLANTATION (2000)
Share Paper
